Eli Lilly said it plans to build three new plants in the United States to make the key ingredients used in pharmaceuticals, ...

Healthcare company stocks ended lower on a rough day for biotech companies and medical providers. Molina Healthcare and Centene notched big declines the day after a House budget resolution threatened ...

In a Chinese trial, trastuzumab rezetecan induced a 73% response rate in previously treated HER2-mutant non-small cell lung cancer (NSCLC). The safety profile of the novel antibody-drug conjugate was ...